MKI67 and breast carcinoma: Compared with the mimic NC group, the EdU-positive expression rate was obviously reduced, and the expression of RRM2, Ki67, and PCNA decreased in the miR-4500 mimic group (all p < 0.05), indicating that breast cancer cell proliferation was attenuated.